Board of Directors

Home » About CureSearch » Board of Directors

CureSearch Directors provide outstanding executive leadership, experience and expertise from the areas of business, finance, medical research, and more. Many directors have experienced childhood cancer in their own families or with close friends, and they understand the challenges facing patients and families today.

Chair of the Board

Jared Brancazio, WMS®
Currently VP, Investments at Brancazio Wealth Management of Raymond James, Mr. Brancazio has spent more than 20 years in high level finance and investment roles and has also served in key volunteer leadership roles at organizations including the Leukemia & Lymphoma Society, Florida Cancer Specialists Foundation and Florida Southwestern State College Foundation. Mr. Brancazio, himself a cancer survivor, previously served as Board Treasurer.

Secretary

Suzanne Finnegan

Suzanne Finnegan
Director & Chief Credit Officer at Build America Mutual

Assurance Company

Treasurer

Trent Demulling

Trent Demulling
Chief Financial Officer at Kiewit

Members

Ali Frost

Ali Frost
CMO, The Bay Golf Club

Brenda Weigel

Brenda Weigel, MD
Chair, Scientific Advisory Council

Vice President, Clinical Research Industry Engagement at St. Jude Children's Research Hospital

Cason Carter

Cason Carter
Director, Head of Public Affairs at Citadel, LLC

Dave Kupiec

Dave Kupiec
CEO/Founder at KPI Media Partners

Dave Whan

Dave Whan
Executive Partner - CHRO at Gartner

Greg Hill, CureSearch Board of Directors

Greg Hill
Executive VP, Kiewit Infrastructure Group Inc.

Mike Miller

Mike Miller, Esquire
Emeritus, Board of Directors
Senior Council at Fisher & Phillips, LLP

Jeffrey Skolnik

Jeffrey Skolnik
Industry Advisory Council Chair
Senior Vice President of Clinical Development at Inovio

 

Kathy Wanner

Kathy Wanner
Founding Partner at Fairway Capital Management

Shari Collier (1)

Stacey Adam, PhD
Vice President, Science Partnerships at Foundation for the National Institutes of Health

Sam Blackman

Sam Blackman, MD, PhD
Co-Founder & Chief Medical Officer
at Day One Biopharmaceuticals

Shari Collier

Shari Collier
Division CFO at St. David's HealthCare

Stu Siegel

Stu E. Siegel, MD
Chair Emeritus, Board of Directors

Retired Director at Children's
Hospital Los Angeles

Tina Swallow

Tina Swallow
Senior Director, US Federal Services and Solutions Sales at HP

Untitled design (38)

John Polson
Chairman and Managing Partner of Fisher Phillips

Placeholder

Paula and Mike Carter
Members, Emeriti
Co-Founders, Scott Carter Foundation

Strategy Oversight Committee

The Strategy Oversight Committee fosters a cooperative, interactive strategic planning process between the Board and management.

Stacey Adam, PhD, Chair
Associate Vice President, Research Partnerships
Foundation for the National Institutes of Health

Members

Cason Carter
Director, Head of Public Affairs
Citadel, LLC

Samuel C. Blackman, MD, PhD,
Co-founder & Chief Medical Officer
Day One Biopharmaceuticals

Syril Petit
Executive Director
Health and Environmental Sciences Institute (HESI)

Chris Lee
Managing Director, Strategy & Corporate Development
Palladium

Gordon Cohen
Global Clinical Head
AstraZeneca

Lou Stancato, PhD
VP of Enabling Technologies and Global Leader of the Pediatric Rare Disease Platform
Indiana Biosciences Research Institute

Pin It on Pinterest

Curesearch for Children's Cancer logo
Suzanne Finnegan
Trent Demulling
Ali Frost
Brenda Weigel
Cason Carter
Dave Kupiec
Dave Whan
Greg Hill, CureSearch Board of Directors
Mike Miller
Jeffrey Skolnik
Kathy Wanner
Shari Collier (1)
Sam Blackman
Shari Collier
Stu Siegel
Tina Swallow
Untitled design (38)
Placeholder